Independent news has never been so important.

Did you know that you can get Democracy Now! delivered to your inbox every day? Sign up for our Daily News Digest today! Don't worry, we'll never share or sell your information.

Merck Applies for Emergency Use of Antiviral Drug That Could Halve Number of Severe COVID Cases

HeadlineOct 01, 2021

The United States reported more than 2,700 COVID-19 deaths on Thursday as the official U.S. pandemic death toll rapidly approached 700,000. Today the drug company Merck announced it’s seeking emergency use of its antiviral drug molnupiravir from the FDA and other regulators around the world, after a late-stage clinical trial showed it reduced the risk of hospitalization or death in COVID-19 patients by about half. If approved, the pill would be the first oral antiviral treatment for COVID-19.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation